Prof. Tim Tully Dart Neuroscience LLC, USA

Timothy Tully has studied the genetic basis of memory for his entire career. Dr. Tully discovered that a gene called CREB plays an important role in regulating the conversion of memory from “short-term” to “long-term.” This finding suggested that CREB pathway-enhancing drugs might enhance memory and, therefore, would be useful... read morein treating memory-related disorders such as Alzheimer’s disease. To that end, Dr. Tully helped to found Helicon Therapeutics, Inc. in 1997, where he remains Acting Chief Scientific Officer and a member of its Board of Directors. Dr. Tully received BS degrees in both biology and psychology from the University of Illinois in 1976 and a PhD in genetics in 1981. He then pursued postdoctoral training in neurogenetics at Princeton University and in molecular genetics at MIT. Prof. Tully joined Dart Neuroscience LLC in 2007 as Chief Science Officer.